Dr. Grey AI

Pinealon

Peptide

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by Russian researchers as part of the Khavinson peptide bioregulators. It is designed to target brain tissue and has been studied for potential neuroprotective and cognitive-enhancing effects. Research suggests it may help regulate circadian rhythms and support cognitive function in aging, though human clinical data is limited.

Quick Answer

What it is

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by Russian researchers as part of the Khavinson peptide bioregulators. It is designed to target brain tissue and has been studied for potential neuroprotective and cognitive-enhancing effects.

Key findings

  • Grade C: Cognitive Performance (Cognitive Function)
  • Grade C: Sleep Quality
  • Grade D: Neuroprotection (Neurological Health)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

⚠️ Research Notice

This peptide information is for educational and research purposes only. Peptides may not be FDA-approved for human use and may only be legally available for research purposes. Consult qualified healthcare professionals before considering any peptide compounds.

ℹ️ Quick Facts: Pinealon

Quick Facts: Pinealon

  • Best Evidence:Grade C
  • Conditions Studied:3
  • Research Outcomes:4
  • Key Effect:Cognitive Function
A0
B0
C2
D2
3 conditions · 4 outcomes

Detailed Outcomes

|
C
Cognitive Performance
Small Increase
small↑Improves
C
Sleep Quality
Small Increase
small↑Improves
D
Neuroprotection
Minor Effect
small↑Improves
D
Oxidative Stress
2 preclinical studies support this finding. Primarily preclinical evidence.
small↓Improves

Related Peptides

Semax

Peptide

2 shared conditions · 14 outcomes

Semax is a synthetic heptapeptide derived from ACTH (adrenocorticotropic hormone). It has been approved as a prescription medication in Russia and Ukraine for treating stroke, cognitive disorders, and peptic ulcers. Research suggests it may enhance BDNF expression and exhibit nootropic and neuroprotective effects. Most clinical research has been conducted in Russia, with limited Western clinical trials.

Humanin

Peptide

2 shared conditions · 23 outcomes

Humanin (HN) is a 24-amino-acid mitochondrial-derived peptide encoded within the 16S rRNA gene of mitochondrial DNA. Discovered in 2001 from preserved brain tissue of Alzheimer's patients, it demonstrates potent neuroprotective, cytoprotective, and metabolic regulatory effects. Humanin levels decline with age but remain stable in long-lived species and are elevated in offspring of centenarians.

Tesamorelin

Peptide

1 shared condition · 15 outcomes

Tesamorelin is a 44-amino-acid synthetic analog of growth hormone-releasing hormone (GHRH) that is FDA-approved (2010) for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. It stimulates endogenous pulsatile GH secretion from the pituitary gland. Tesamorelin has demonstrated efficacy in reducing visceral adipose tissue, liver fat (NAFLD), and improving cognitive function in clinical trials.